Aprea Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 12/08/2026 | Mar 2026Filed 12/08/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 12/08/2026 | Mar 2025Filed 12/08/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 12/11/2025 | Mar 2024Filed 12/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$3.6 | −$3.3 | −$3 | −$3.2 | −$3.9 | −$3.8 | −$3.5 | −$2.8 | |
| −$0.07 | −$0.22 | −$0.47 | −$0.53 | −$0.66 | −$0.64 | −$0.58 | −$0.67 | |
| 53 | 15 | 6.4 | 6.1 | 6 | 5.9 | 5.9 | 4.2 |
Trend